%20(28).png)
The FDA recently issued dozens of warning letters and proposed removing compounded semaglutide and tirzepatide from the 503B Bulks List. This ongoing crackdown highlights the immediate need for telehealth operators to ensure robust clinical oversight and appropriate clinician-to-patient ratios rather than relying on automated visit templates.
.png)
.png)
Recruiting for virtual care often hits a wall: the "Epic gap." Discover why waiting months for specialized talent is costing health systems up to $400k and how to source production-ready physicians who can hit the ground running.


As a healthcare provider or organization, the looming "telehealth policy cliff" is not a distant threat; it's an urgent deadline. On October 1, 2025, critical telehealth flexibilities that have been in place since the COVID-19 pandemic are set to expire.

As healthcare increasingly intersects with technology, Microsoft is making bold strides toward developing medical superintelligence, a system designed to analyze massive amounts of medical data and deliver insights that could transform patient care.

Subscribe to receive your monthly dose of clinical news, insights & jobs.